Humoral Hypercalcemia Of Malignancy: Clinical Trials

1 trial for Humoral Hypercalcemia Of Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1

Follow Humoral Hypercalcemia Of Malignancy: new trials by email Literature Review of Humoral Hypercalcemia Of Malignancy trials Research Report on Humoral Hypercalcemia Of Malignancy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
PTHrP (1-36) - Osteoporosis, Humoral Hypercalcemia of Malignancy
Early Phase 1CompletedUniversity of Pittsburgh142008-01-012016-02-11

Narrower conditions

Endocrine System Diseases (1)  ·  Hyperparathyroidism (1)  ·  Musculoskeletal Diseases (1)  ·  Neoplasms (1)  ·  Osteoporosis (1)

Broader conditions

Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Parathyroid Diseases (1)

Interventions

parathyroid hormone-related peptide (1-36) (1)

Sponsors

University of Pittsburgh (1)

Countries

United States (1)

Top investigators

Mara J Horwitz, MD (1)

Results publications

PMID 21544866

NIH funding

R01DK073039 (1)